BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Ruud Weijer, Séverine Clavier, Esther A. Zaal, Maud M. E. Pijls, Robert T. van Kooten, Klaas Vermaas, René Leen, Aldo Jongejan, Perry D. Moerland, Antoine H. C. van Kampen, André B. P. van Kuilenburg, Celia R. Berkers, Simone Lemeer, Michal Heger. Multi-OMIC profiling of survival and metabolic signaling networks in cells subjected to photodynamic therapyCellular and Molecular Life Sciences 2017; 74(6): 1133 doi: 10.1007/s00018-016-2401-0
2
Audrey Clapéron, Martine Mergey, Thanh Huong Nguyen Ho-Bouldoires, Danijela Vignjevic, Dominique Wendum, Yves Chrétien, Fatiha Merabtene, Alexandra Frazao, Valérie Paradis, Chantal Housset, Nathalie Guedj, Laura Fouassier. EGF/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transitionJournal of Hepatology 2014; 61(2): 325 doi: 10.1016/j.jhep.2014.03.033
3
Audrey Clapéron, Martine Mergey, Lynda Aoudjehane, Thanh Huong Nguyen Ho-Bouldoires, Dominique Wendum, Aurélie Prignon, Fatiha Merabtene, Delphine Firrincieli, Christèle Desbois-Mouthon, Olivier Scatton, Filomena Conti, Chantal Housset, Laura Fouassier. Hepatic myofibroblasts promote the progression of human cholangiocarcinoma through activation of epidermal growth factor receptorHepatology 2013; 58(6): 2001 doi: 10.1002/hep.26585
4
Munita Meenu Bal, Mukta Ramadwar, Kedar Deodhar, Shailesh Shrikhande. Pathology of Gallbladder Carcinoma: Current Understanding and New PerspectivesPathology & Oncology Research 2015; 21(3): 509 doi: 10.1007/s12253-014-9886-3
5
Ruud Weijer, Mans Broekgaarden, Milan Kos, Remko van Vught, Erik A.J. Rauws, Eefjan Breukink, Thomas M. van Gulik, Gert Storm, Michal Heger. Enhancing photodynamic therapy of refractory solid cancers: Combining second-generation photosensitizers with multi-targeted liposomal deliveryJournal of Photochemistry and Photobiology C: Photochemistry Reviews 2015; 23: 103 doi: 10.1016/j.jphotochemrev.2015.05.002
6
Carolina Bizama, Patricia García, Jaime A. Espinoza, Helga Weber, Pamela Leal, Bruno Nervi, Juan Carlos Roa. Targeting specific molecular pathways holds promise for advanced gallbladder cancer therapyCancer Treatment Reviews 2015; 41(3): 222 doi: 10.1016/j.ctrv.2015.01.003
7
Takamitsu Sasaki, Hiroki Kuniyasu, Yi Luo, Daisuke Kato, Satoshi Shinya, Kiyomu Fujii, Hitoshi Ohmori, Yuichi Yamashita. Significance of epithelial growth factor in the epithelial-mesenchymal transition of human gallbladder cancer cellsCancer Science 2012; 103(6): 1165 doi: 10.1111/j.1349-7006.2012.02264.x
8
Eduardo E. Montalvo-Jave, Amir A. Rahnemai- Azar, Dimitrios Papaconstantinou, Mariana Espejel Deloiza, Diamantis I. Tsilimigras, Dimitrios Moris, German Eduardo Mendoza-Barrera, Sharon M. Weber, Timothy M. Pawlik. Molecular pathways and potential biomarkers in gallbladder cancer: A comprehensive reviewSurgical Oncology 2019; 31: 83 doi: 10.1016/j.suronc.2019.09.006
9
Changhe Zhang, Hong Xu, Zhenping Zhou, Ye Tian, Xiaofei Cao, Guochang Cheng, Qinghong Liu. Blocking of the EGFR‑STAT3 signaling pathway through afatinib treatment inhibited the intrahepatic cholangiocarcinomaExperimental and Therapeutic Medicine 2018;  doi: 10.3892/etm.2018.6038
10
Do-Youn Oh, Yung-Jue Bang. HER2-targeted therapies — a role beyond breast cancerNature Reviews Clinical Oncology 2020; 17(1): 33 doi: 10.1038/s41571-019-0268-3
11
Hee Jin Lee, Joon-Yong Chung, Stephen M. Hewitt, Eunsil Yu, Seung-Mo Hong. HER3 overexpression is a prognostic indicator of extrahepatic cholangiocarcinomaVirchows Archiv 2012; 461(5): 521 doi: 10.1007/s00428-012-1321-0
12
A F Hezel, M S Noel, J N Allen, T A Abrams, M Yurgelun, J E Faris, L Goyal, J W Clark, L S Blaszkowsky, J E Murphy, H Zheng, A A Khorana, G C Connolly, O Hyrien, A Baran, M Herr, K Ng, S Sheehan, D J Harris, E Regan, D R Borger, A J Iafrate, C Fuchs, D P Ryan, A X Zhu. Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancerBritish Journal of Cancer 2014; 111(3): 430 doi: 10.1038/bjc.2014.343
13
JINGLI CAI, LUBAI XU, ZHENZHAI CAI, JISHENG WANG, BING ZHOU, HAI HU. MicroRNA-146b-5p inhibits the growth of gallbladder carcinoma by targeting epidermal growth factor receptorMolecular Medicine Reports 2015; 12(1): 1549 doi: 10.3892/mmr.2015.3461
14
Nicola Fusco, Silvano Bosari. <i>HER2</i> aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologistsWorld Journal of Gastroenterology 2016; 22(35): 7926-7937 doi: 10.3748/wjg.v22.i35.7926
15
Siobhan C. McKay, Kristian Unger, Stephanos Pericleous, Gordon Stamp, Gerry Thomas, Robert R. Hutchins, Duncan R.C. Spalding. Array comparative genomic hybridization identifies novel potential therapeutic targets in cholangiocarcinomaHPB 2011; 13(5): 309 doi: 10.1111/j.1477-2574.2010.00286.x
16
Hyun-Jin Nam, Hwang-Phill Kim, Young-Kwang Yoon, Sang-Hyun Song, Ah-Rum Min, Sae-Won Han, Seock-Ah Im, Tae-You Kim, Do-Youn Oh, Yung-Jue Bang. The irreversible pan-HER inhibitor PF00299804 alone or combined with gemcitabine has an antitumor effect in biliary tract cancer cell linesInvestigational New Drugs 2012; 30(6): 2148 doi: 10.1007/s10637-011-9782-6
17
Zongming E. Chen, Jeffrey Prichard, Fan Lin. Handbook of Practical Immunohistochemistry2015; : 503 doi: 10.1007/978-1-4939-1578-1_26
18
Karin Komposch, Maria Sibilia. EGFR Signaling in Liver DiseasesInternational Journal of Molecular Sciences 2015; 17(1): 30 doi: 10.3390/ijms17010030
19
Joshua Peck, Lai Wei, Mark Zalupski, Bert O’Neil, Miguel Villalona Calero, Tanios Bekaii-Saab. HER2/neu May Not Be an Interesting Target in Biliary Cancers: Results of an Early Phase II Study with LapatinibOncology 2012; 82(3): 175 doi: 10.1159/000336488
20
Thomas Albrecht, Melina Rausch, Stephanie Rössler, Michael Albrecht, Jana Dorothea Braun, Veronika Geissler, Arianeb Mehrabi, Monika Nadja Vogel, Anita Pathil-Warth, Gunhild Mechtersheimer, Marcus Renner, Christian Rupp, Karl Heinz Weiss, Elena Busch, Bruno Köhler, Christoph Springfeld, Peter Schirmacher, Benjamin Goeppert. HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesisBMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-6320-y
21
Jeffrey Prichard, Fan Lin. Handbook of Practical Immunohistochemistry2011; : 389 doi: 10.1007/978-1-4419-8062-5_23
22
J Harder, G Ihorst, V Heinemann, R Hofheinz, M Moehler, P Buechler, G Kloeppel, C Röcken, M Bitzer, S Boeck, E Endlicher, A Reinacher-Schick, C Schmoor, M Geissler. Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancerBritish Journal of Cancer 2012; 106(6): 1033 doi: 10.1038/bjc.2012.18
23
Sagun Parakh, Hui K. Gan, Adam C. Parslow, Ingrid J.G. Burvenich, Antony W. Burgess, Andrew M. Scott. Evolution of anti-HER2 therapies for cancer treatmentCancer Treatment Reviews 2017; 59: 1 doi: 10.1016/j.ctrv.2017.06.005
24
RODRIGO VIEIRA GOMES, MICHELE ÂNGELA RODRIGUES, JOÃO BERNARDO SANCIO ROCHA RODRIGUES, PAULA TEIXEIRA VIDIGAL, KARINE ARAÚJO DAMASCENO, HENRIQUE ARAÚJO LIMA, DAWIDSON ASSIS GOMES, CARLA JORGE MACHADO, VIVIAN RESENDE. Expression of epidermal growth factor receptor (EGFR) in cholangiocarcinomas: predictive factors and survivalRevista do Colégio Brasileiro de Cirurgiões 2018; 45(3) doi: 10.1590/0100-6991e-20181826
25
Beata Hryciuk, Rafał Pęksa, Michał Bieńkowski, Bartosz Szymanowski, Barbara Radecka, Kamil Winnik, Jolanta Żok, Natalia Cichowska, Mariola Iliszko, Renata Duchnowska. Expression of Female Sex Hormone Receptors, Connective Tissue Growth Factor and HER2 in Gallbladder CancerScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-58777-y
26
XIAOQING YANG, WEISHAN WANG, CHUNNI WANG, LIN WANG, MUYI YANG, MEI QI, HONG SU, XIUBIN SUN, ZHIYAN LIU, JUAN ZHANG, XIAOMIN QIN, BO HAN. Characterization of EGFR family gene aberrations in cholangiocarcinomaOncology Reports 2014; 32(2): 700 doi: 10.3892/or.2014.3261
27
Shou-Hua Wang, Fei Ma, Zhao-hui Tang, Xiao-Cai Wu, Qiang Cai, Ming-Di Zhang, Ming-Zhe Weng, Di Zhou, Jian-Dong Wang, Zhi-Wei Quan. Long non-coding RNA H19 regulates FOXM1 expression by competitively binding endogenous miR-342-3p in gallbladder cancerJournal of Experimental & Clinical Cancer Research 2016; 35(1) doi: 10.1186/s13046-016-0436-6
28
Sanjeev K. Maurya, Mallika Tewari, Raghvendra R. Mishra, Hari S. Shukla. Genetic abberations in gallbladder cancerSurgical Oncology 2012; 21(1): 37 doi: 10.1016/j.suronc.2010.09.003
29
Edward L Nelson. HER2/neu: an increasingly important therapeutic target. Part 2: Distribution of HER2/neu overexpression and gene amplification by organ, tumor site and histologyClinical Investigation 2014; 4(8): 705 doi: 10.4155/cli.14.62
30
Masaaki Yokoyama, Hiroaki Ohnishi, Kouki Ohtsuka, Satsuki Matsushima, Yasuo Ohkura, Junji Furuse, Takashi Watanabe, Toshiyuki Mori, Masanori Sugiyama. KRAS Mutation as a Potential Prognostic Biomarker of Biliary Tract CancersJapanese Clinical Medicine 2016; 7: JCM.S40549 doi: 10.4137/JCM.S40549
31
Sirinapha Klungsaeng, Veerapol Kukongviriyapan, Auemduan Prawan, Sarinya Kongpetch, Laddawan Senggunprai. Targeted Modulation of FAK/PI3K/PDK1/AKT and FAK/p53 Pathways by Cucurbitacin B for the Antiproliferation Effect Against Human Cholangiocarcinoma CellsThe American Journal of Chinese Medicine 2020; 48(06): 1475 doi: 10.1142/S0192415X2050072X
32
Takuya Kitamura, Jaya Srivastava, John DiGiovanni, Kaoru Kiguchi. Bile acid accelerates erbB2-induced pro-tumorigenic activities in biliary tract cancerMolecular Carcinogenesis 2015; 54(6): 459 doi: 10.1002/mc.22118
33
Davendra P.S. Sohal, Shiva Shrotriya, Mohamed Abazeed, Michael Cruise, Alok Khorana. Molecular characteristics of biliary tract cancerCritical Reviews in Oncology/Hematology 2016; 107: 111 doi: 10.1016/j.critrevonc.2016.08.013
34
Andriana Inkoom, Nkafu Ndemazie, Kevin Affram, Taylor Smith, Xue Zhu, Patrick Underwood, Sunil Krishnan, Edward Ofori, Bo Han, Jose Trevino, Edward Agyare. Enhancing efficacy of gemcitabine in pancreatic patient-derived xenograft mouse modelsInternational Journal of Pharmaceutics: X 2020; 2: 100056 doi: 10.1016/j.ijpx.2020.100056
35
S.G. Barreto, A. Dutt, A. Chaudhary. A genetic model for gallbladder carcinogenesis and its disseminationAnnals of Oncology 2014; 25(6): 1086 doi: 10.1093/annonc/mdu006
36
Salvatore Galdy, Angela Lamarca, Mairéad G. McNamara, Richard A. Hubner, Chiara A. Cella, Nicola Fazio, Juan W. Valle. HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target?Cancer and Metastasis Reviews 2017; 36(1): 141 doi: 10.1007/s10555-016-9645-x
37
QING-FENG NI, JIA-WEI YU, FEI QIAN, NAI-ZHI SUN, JIAN-JIA XIAO, JIAN-WEI ZHU. Cortactin promotes colon cancer progression by regulating ERK pathwayInternational Journal of Oncology 2015; 47(3): 1034 doi: 10.3892/ijo.2015.3072
38
Abigale Lade, Satdarshan P. S. Monga. Molecular Pathology of Liver DiseasesMolecular Pathology Library 2011; 5: 291 doi: 10.1007/978-1-4419-7107-4_20
39
Caterina Peraldo-Neia, Giuliana Cavalloni, Elisabetta Fenocchio, Celeste Cagnazzo, Loretta Gammaitoni, Stefano Cereda, Guglielmo Nasti, Maria Antonietta Satolli, Giuseppe Aprile, Michele Reni, Antonio Avallone, Rosella Spadi, Tiziana Venesio, Vittoria Martin, Claudio Doglioni, Milo Frattini, Massimo Aglietta, Francesco Leone, John Souglakos. Prognostic and predictive role of EGFR pathway alterations in biliary cancer patients treated with chemotherapy and anti-EGFRPLOS ONE 2018; 13(1): e0191593 doi: 10.1371/journal.pone.0191593
40
Jason K. Sicklick, Paul T. Fanta, Kelly Shimabukuro, Razelle Kurzrock. Genomics of gallbladder cancer: the case for biomarker-driven clinical trial designCancer and Metastasis Reviews 2016; 35(2): 263 doi: 10.1007/s10555-016-9602-8
41
Jesus M. Banales, Vincenzo Cardinale, Guido Carpino, Marco Marzioni, Jesper B. Andersen, Pietro Invernizzi, Guro E. Lind, Trine Folseraas, Stuart J. Forbes, Laura Fouassier, Andreas Geier, Diego F. Calvisi, Joachim C. Mertens, Michael Trauner, Antonio Benedetti, Luca Maroni, Javier Vaquero, Rocio I. R. Macias, Chiara Raggi, Maria J. Perugorria, Eugenio Gaudio, Kirsten M. Boberg, Jose J. G. Marin, Domenico Alvaro. Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)Nature Reviews Gastroenterology & Hepatology 2016; 13(5): 261 doi: 10.1038/nrgastro.2016.51
42
Laura W. Goff, Dana B. Cardin, Jennifer G. Whisenant, Liping Du, Tatsuki Koyama, Kimberly B. Dahlman, Safia N. Salaria, Ruth T. Young, Kristen K. Ciombor, Jill Gilbert, Stephen James Smith, Emily Chan, Jordan Berlin. A phase I trial investigating pulsatile erlotinib in combination with gemcitabine and oxaliplatin in advanced biliary tract cancersInvestigational New Drugs 2017; 35(1): 95 doi: 10.1007/s10637-016-0406-z
43
John D. Hainsworth, Funda Meric-Bernstam, Charles Swanton, Herbert Hurwitz, David R. Spigel, Christopher Sweeney, Howard A. Burris, Ron Bose, Bongin Yoo, Alisha Stein, Mary Beattie, Razelle Kurzrock. Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket StudyJournal of Clinical Oncology 2018; 36(6): 536 doi: 10.1200/JCO.2017.75.3780
44
B. N. Gurmikov, D. V. Kalinin, I. G. Nikitin, T. A. Zhinzhilo, A. N. Shipilova, A. V. Chzhao. Frequency and effects of mutations in the KRAS gene on the survival of patients after surgical treatment of intrahepatic cholangiocarcinomaKuban Scientific Medical Bulletin 2020; 27(2): 59 doi: 10.25207/1608-6228-2020-27-2-59-69
45
Thomas Albrecht, Melina Rausch, Stephanie Roessler, Veronika Geissler, Michael Albrecht, Christine Halske, Carolin Seifert, Marcus Renner, Stephan Singer, Arianeb Mehrabi, Monika Nadja Vogel, Anita Pathil-Warth, Elena Busch, Bruno Köhler, Christian Rupp, Karl Heinz Weiss, Christoph Springfeld, Christoph Röcken, Peter Schirmacher, Benjamin Goeppert. HER2 gene (ERBB2) amplification is a low-frequency driver with potential predictive value in gallbladder carcinomaVirchows Archiv 2020; 476(6): 871 doi: 10.1007/s00428-019-02706-6
46
Kentaro Sawada, Yoshiaki Nakamura, Kohei Shitara. Development of HER2-targeted Therapies for Gastrointestinal CancerEuropean Oncology & Haematology 2020; 16(1): 29 doi: 10.17925/EOH.2020.16.1.29
47
Alper Ata, Ayşe Polat, Ebru Serinsöz, Mehmet Ali Sungur, Ali Arican. Prognostıc Value of Increased her2 Expression in Cancers of Pancreas and Biliary TreePathology & Oncology Research 2015; 21(3): 831 doi: 10.1007/s12253-014-9847-x
48
Heather Francis, Gianfranco Alpini, Sharon DeMorrow. Recent advances in the regulation of cholangiocarcinoma growthAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2010; 299(1): G1 doi: 10.1152/ajpgi.00114.2010
49
Pattaya Seeree, Phorutai Pearngam, Supeecha Kumkate, Tavan Janvilisri. An Omics Perspective on Molecular Biomarkers for Diagnosis, Prognosis, and Therapeutics of CholangiocarcinomaInternational Journal of Genomics 2015; 2015: 1 doi: 10.1155/2015/179528
50
Hasaya Dokduang, Wassana Jamnongkarn, Bundit Promraksa, Manida Suksawat, Sureerat Padthaisong, Malinee Thanee, Jutarop Phetcharaburanin, Nisana Namwat, Sakkarn Sangkhamanon, Attapol Titapun, Narong Khuntikeo, Poramate Klanrit, Watcharin Loilome. <p>In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines</p>Drug Design, Development and Therapy 2020; : 2319 doi: 10.2147/DDDT.S250061
51
Taylor Smith, Kevin Affram, Ebony L. Nottingham, Bo Han, Felix Amissah, Sunil Krishnan, Jose Trevino, Edward Agyare. Application of smart solid lipid nanoparticles to enhance the efficacy of 5-fluorouracil in the treatment of colorectal cancerScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-73218-6
52
Takamitsu Sasaki, Kuniyasu Hiroki, Yuichi Yamashita. The Role of Epidermal Growth Factor Receptor in Cancer Metastasis and MicroenvironmentBioMed Research International 2013; 2013: 1 doi: 10.1155/2013/546318
53
Milind Javle, Tanios Bekaii-Saab, Apurva Jain, Ying Wang, Robin Katie Kelley, Kai Wang, Hyunseon C. Kang, Daniel Catenacci, Siraj Ali, Sunil Krishnan, Daniel Ahn, Andrea Grace Bocobo, Mingxin Zuo, Ahmed Kaseb, Vincent Miller, Philip J. Stephens, Funda Meric-Bernstam, Rachna Shroff, Jeffrey Ross. Biliary cancer: Utility of next-generation sequencing for clinical managementCancer 2016; 122(24): 3838 doi: 10.1002/cncr.30254
54
Hui-Yi Feng, Yang-Chao Chen. Role of bile acids in carcinogenesis of pancreatic cancer: An old topic with new perspectiveWorld Journal of Gastroenterology 2016; 22(33): 7463-7477 doi: 10.3748/wjg.v22.i33.7463
55
Thannicha Sae-Lao, Rutaiwan Tohtong, David O. Bates, Kanokpan Wongprasert. Sulfated Galactans from Red Seaweed Gracilaria fisheri Target EGFR and Inhibit Cholangiocarcinoma Cell ProliferationThe American Journal of Chinese Medicine 2017; 45(03): 615 doi: 10.1142/S0192415X17500367
56
Darren Chyi-Hsiang Kong, Kenneth Yee Chew, Eng Tan, Suan Khoo. The effect of epiregulin on epidermal growth factor receptor expression and proliferation of oral squamous cell carcinoma cell linesCancer Cell International 2014; 14(1): 65 doi: 10.1186/1475-2867-14-65
57
Nobuyoshi Hiraoka, Hiroaki Nitta, Akihiro Ohba, Hiroshi Yoshida, Chigusa Morizane, Takuji Okusaka, Satoshi Nara, Minoru Esaki, Yoji Kishi, Kazuaki Shimada. Details of human epidermal growth factor receptor 2 status in 454 cases of biliary tract cancerHuman Pathology 2020; 105: 9 doi: 10.1016/j.humpath.2020.08.006
58
Patricia García, Carolina Bizama, Lorena Rosa, Jaime A. Espinoza, Helga Weber, Javier Cerda-Infante, Marianela Sánchez, Viviana P. Montecinos, Justo Lorenzo-Bermejo, Felix Boekstegers, Marcela Dávila-López, Francisca Alfaro, Claudia Leiva-Acevedo, Zasha Parra, Diego Romero, Sumie Kato, Pamela Leal, Marcela Lagos, Juan Carlos Roa. Functional and genomic characterization of three novel cell lines derived from a metastatic gallbladder cancer tumorBiological Research 2020; 53(1) doi: 10.1186/s40659-020-00282-7
59
Sergio Renato PAIS-COSTA, José Francisco de Matos FARAH, Ricardo ARTIGIANI-NETO, Sandro José MARTINS, Alberto GOLDENBERG. Evaluation of P53, E-cadherin, Cox-2, and EGFR protein imunnoexpression on prognostic of resected gallbladder carcinomaABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) 2014; 27(2): 126 doi: 10.1590/S0102-67202014000200009
60
Zichen Zhang, Regina A. Oyesanya, Deanna J. W. Campbell, Jorge A. Almenara, Jennifer L. DeWitt, Alphonse E. Sirica. Preclinical assessment of simultaneous targeting of epidermal growth factor receptor (ErbB1) and ErbB2 as a strategy for cholangiocarcinoma therapyHepatology 2010; 52(3): 975 doi: 10.1002/hep.23773
61
Norhayati Omar, Benedict Yan, Manuel Salto-Tellez. HER2: An emerging biomarker in non-breast and non-gastric cancersPathogenesis 2015; 2(3): 1 doi: 10.1016/j.pathog.2015.05.002
62
Min Yan, Barbara A. Parker, Richard Schwab, Razelle Kurzrock. HER2 aberrations in cancer: Implications for therapyCancer Treatment Reviews 2014; 40(6): 770 doi: 10.1016/j.ctrv.2014.02.008
63
Hiroshi Yoshida, Kazuaki Shimada, Tomoo Kosuge, Nobuyoshi Hiraoka. A significant subgroup of resectable gallbladder cancer patients has an HER2 positive statusVirchows Archiv 2016; 468(4): 431 doi: 10.1007/s00428-015-1898-1